Dasatinib inhibits primary melanoma cell proliferation through morphologydependent disruption of SrcERK signaling
Publisher: Spandidos Publications
ISSN: 1792-1074
Source: Oncology Letters, Vol.5, Iss.2, 2013-01, pp. : 527-532
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract